Pnc Financial Services Group, Inc. Anavex Life Sciences Corp. Transaction History
Pnc Financial Services Group, Inc.
- $143 Billion
- Q1 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 22,954 shares of AVXL stock, worth $94,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,954
Previous 17,732
29.45%
Holding current value
$94,570
Previous $165,000
29.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AVXL
# of Institutions
159Shares Held
31.6MCall Options Held
910KPut Options Held
1.35M-
State Street Corp Boston, MA7.3MShares$30.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$27.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$18.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$7.06 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC851KShares$3.51 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $321M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...